English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Hua Medicine Announces 2021 Annual Results
Mar 17, 2022 10:50 HKT
IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Approved by FDA
Mar 14, 2022 20:32 HKT
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60%
Mar 14, 2022 19:58 HKT
EC Healthcare Launch Tele-Medicine and Drug Delivery Service, Reduce Infection Risk and Protect Citizen's Health
Mar 09, 2022 15:15 HKT
EC Healthcare's Chairman Eddy Tang Further Increases Shareholdings With Strong Confidence in the Group's Future Development
Mar 09, 2022 09:39 HKT
EC Healthcare Included as an Eligible Stock of the Shenzhen - Hong Kong Stock Connect
Mar 07, 2022 12:45 HKT
EC Healthcare and ClinicONE jointly launch A.I. Remote Nursing Program
Mar 07, 2022 10:43 HKT
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets
Mar 04, 2022 22:30 HKT
Avance Clinical Announces New Office Opening in Sydney
Mar 02, 2022 15:00 HKT
Senior Management Further Increases Shareholdings in EC Healthcare With Strong Confidence in the Group's Future Development
Feb 28, 2022 18:29 HKT
Lepu Biopharma Co., Ltd. Successfully Listed on the Main Board of HKEX
Feb 23, 2022 18:11 HKT
Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%
Feb 23, 2022 16:00 HKT
CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021
Feb 23, 2022 16:00 HKT
UMP Healthcare Offers Free Telemedicine Service to COVID-19 Patients
Feb 23, 2022 15:36 HKT
MBMV invests in international bio-tech startup Arcensus GmbH
Feb 22, 2022 11:00 HKT
Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
Feb 21, 2022 12:00 HKT
EC Healthcare Included in the Hang Seng Composite Index & Hang Seng Stock Connect Hong Kong Index
Feb 18, 2022 21:10 HKT
V-01 as a Sequential Booster Can Produce Good Protection against Omicron ---- Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma
Feb 18, 2022 14:37 HKT
IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA
Feb 17, 2022 15:13 HKT
Bintai Kinden Corporation Berhad Emerges as Substantial Shareholder in Malaysian Genomics Resource Centre Berhad
Feb 17, 2022 14:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: